SEPN Septerna, Inc.: Market Value
Septerna Inc (SEPN) develops drugs for cellular receptors, focusing on immune and endocrine pathologies. This price chart demonstrates the asset's market dynamics, where the capitalization stands at 2.49. The business relies on immense scaling potential: following costly research, patents enable the generation of colossal profits. Meanwhile, a neutral political climate and the humanitarian status of the developments minimize external risks for the company.
Comprehensive metric breakdowns and analytics for Septerna Pharma (SEPN)
- current price and projected stock value:
- company stock capitalization data:
- book value of equity indicators:
- debt burden and liquidity indicators:
Total Debt to Capital Septerna Inc|SEPN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Septerna Inc|SEPN - Company Aggregate Debts|Debt to Book Capitalization Ratio Septerna Pharma|SEPN - Company Long-Term Loans and Borrowings|Company Short-Term Debt Septerna|Quick Ratio septerna.com
- business earnings and investment ratios data:
SEPN - Net Profit|Future Profit Septerna Inc|SEPN - Company Value to Net Income|Forward P/E Multiple Septerna Corp|SEPN - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Septerna Pharma|SEPN - Operating profit before deduction of amortization|Earnings per share for the last twelve months Septerna|SEPN - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months septerna.com|SEPN - Earnings growth in current year|Net earnings per share growth forecast for next year Septerna Inc
Fundamental company analysis:SEPN (Septerna)
The innovative potential of Septerna Inc (SEPN) in receptor technologies is directly reflected in its market capitalization, calculated as the product of the current share price and the total number of outstanding securities. This metric measures the aggregate market value of the business, allowing investors to assess the scale of the enterprise and promptly identify signs of asset overheating or financial instability through the company's capitalization chart.
Key competitors
Market Capitalization ARGX (argenx)|BioNTech Inc. (BNTX) - Market Value|ABVX - Market Value|Market Valuation ADMA|Protagonist Therapeutics (PTGX) - Market Value|Market Capitalization IMVT|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|JBIO - Market Value|Market Capitalization Aclaris Therapeutics, Inc ACRS|KYTX: Market Capitalization|Market Value tizianalifesciences.com (TLSA)|Market Value Cabaletta Bio|Ventyx Biosciences Inc. - Market Valuation|Market Valuation THTX (Theratechnologies Inc)|Market Value AVTX|Market Capitalization ELDN (Eledon Pharmaceuticals)|agenusbio.com (AGEN) - Market Value|CLYM - Market Value|Market Value ZURA (zurabio.com)|aTyr (ATYR) - Market Value|Market Capitalization ADAG|IMA (ImageneBio) - Market Capitalization|Market Capitalization Shattuck Therapeutics|Market Valuation EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Market Value|Market Capitalization IMUX (Immunic)|Market Capitalization Atara Biotherapeutics, Inc. (ATRA)|IFRX - Market Value|XFOR (x4pharma.com) - Market Capitalization|ACET: Market Capitalization|Market Valuation Celularity|Market Value INmune Bio Corp|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Capitalization KZR|SABS - Market Value|Market Value Akari Therapeutics Plc AKTX|ENLV (Enlivex Therapeutics Ltd) - Market Valuation|QTTB - Market Value|GOVX (GeoVax Corp) - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Valuation IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Market Capitalization|XTLB: Market Value|Market Capitalization BOLT|Market Capitalization hcwbiologics.com (HCWB)|Market Value Aptevo Therapeutics Inc. APVO|Market Value AIM|ADTX - Market Value|GRI Bio Inc (GRI) - Market Valuation|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Valuation REVB|INDP: Market Value|Market Capitalization SCNI|Market Capitalization calcimedica.com|Market Value Affimed N.V. AFMD|ALLK - Market Valuation|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|ITOS (iTeos Therapeutics, Inc.) - Market Valuation|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Capitalization THRD (Third Harmonic Bio Inc)
